| < Prev | Next > |
|---|
There are no translations available.
Hony Capital has made its second partial exit from CSPC Pharmaceutical Group in three months, selling an 11% stake in the Hong Kong-listed Chinese generic drugs maker for HK$4.01 billion ($528 million).
